SADS, or Sudden Arrhythmic Death Syndrome, is an inherited heart condition that disrupts the heart’s electrical system, causing dangerous irregular rhythms that can lead to sudden cardiac death. It typically affects young, apparently healthy people, and in many cases, the first sign of a problem is a cardiac arrest with no prior warning. In England, estimates suggest up to 500 people per year may die from SADS-related causes, and many of those deaths are initially classified as unexplained.
How SADS Differs From a Heart Attack
A heart attack happens when blood flow to part of the heart is blocked, usually by a clot. SADS is fundamentally different. The heart muscle itself is healthy, and the blood vessels are clear. The problem is purely electrical: the signals that coordinate each heartbeat malfunction, sending the heart into a chaotic rhythm that can’t pump blood. This is why a standard autopsy often finds nothing wrong. The heart looks normal under a microscope because the defect lies in the ion channels, tiny protein structures in heart cells that control the flow of charged particles responsible for generating each beat.
About 5% of all medico-legal autopsies come back inconclusive. When an apparently healthy person dies suddenly, within an hour of their first symptom or within 24 hours of last being seen alive, and no structural cause is found, the death is classified as sudden unexplained death. In these cases, an inherited electrical heart disorder is considered the most likely explanation.
The Conditions Behind SADS
SADS is not a single disease. It is an umbrella term for several inherited conditions that share one dangerous trait: they can trigger a fatal heart rhythm without warning. The most common ones are:
- Long QT syndrome (LQTS): The heart takes too long to recharge between beats. This delay can trigger a rapid, twisting rhythm that prevents the heart from pumping effectively. Some people have a normal-looking heart tracing at rest, but the abnormality shows up during exercise or recovery.
- Brugada syndrome: An electrical conduction problem in the right side of the heart that can cause it to suddenly fibrillate, or quiver uselessly instead of beating. It often strikes during sleep or rest.
- CPVT (catecholaminergic polymorphic ventricular tachycardia): The heart rhythm looks completely normal at rest. The danger appears during exercise or emotional stress, when adrenaline triggers increasingly erratic beats that can spiral into a lethal rhythm.
- Short QT syndrome: The opposite of long QT. The heart recharges too quickly between beats, making it vulnerable to both upper and lower chamber fibrillation. This is a relatively recently identified condition and quite rare.
- Wolff-Parkinson-White syndrome: An extra electrical pathway exists between the heart’s upper and lower chambers, allowing signals to bypass the normal route. This can create a dangerously fast heart rate.
Warning Signs to Recognize
The challenge with SADS is that many people have no symptoms at all before a cardiac arrest. When warning signs do appear, they are easy to dismiss or misdiagnose. Unexplained fainting, especially during exercise, swimming, or after being startled by a loud noise, is one of the most important red flags. These episodes happen because the heart briefly loses its rhythm, cutting off blood flow to the brain.
Some people experience what looks like a seizure, but the cause is cardiac rather than neurological. If someone faints or has a seizure-like episode during physical activity and has no history of epilepsy, an underlying heart rhythm disorder should be considered. A family history of unexplained sudden death in a young relative, even if it was attributed to drowning or a car accident, is another significant clue.
How SADS Is Diagnosed
Because many of these conditions hide at rest, diagnosis often requires more than a standard checkup. The first-line tool is a resting ECG, which records the heart’s electrical activity and can reveal a prolonged or shortened recharge interval, or the characteristic pattern seen in Brugada syndrome. But a normal resting ECG does not rule out SADS.
An exercise ECG is a critical next step. For CPVT, increasing irregularity during exercise is a defining feature. For long QT syndrome, a specific measurement taken at the fourth minute of recovery after exercise can unmask the condition even when resting tracings look borderline or normal. An echocardiogram, which uses ultrasound to look at the heart’s structure, helps rule out physical abnormalities.
When initial tests come back normal but suspicion remains high, provocation testing can draw out hidden problems. For suspected Brugada syndrome, a drug that blocks certain sodium channels in the heart is given intravenously. If the characteristic ECG pattern appears, the test is positive. For suspected long QT syndrome, an adrenaline infusion can reveal abnormal electrical behavior that would not show up otherwise.
Genetic testing plays an increasingly important role. A blood or tissue sample can be screened for mutations in the genes that encode the heart’s ion channels. When performed on tissue retained after a death (sometimes called a molecular autopsy), genetic testing provides a definitive diagnosis in up to a third of cases.
What Treatment Looks Like
Treatment depends on which specific condition is identified. For long QT syndrome and CPVT, beta-blockers are often the foundation of treatment. These medications blunt the heart’s response to adrenaline, reducing the chance that exercise or stress will trigger a dangerous rhythm.
For people at higher risk, an implantable cardioverter-defibrillator (ICD) may be recommended. This small device, placed under the skin near the collarbone, continuously monitors the heart’s rhythm. If it detects a life-threatening arrhythmia, it delivers a brief electrical shock to restore normal rhythm. ICDs are the most effective protection against sudden cardiac death in people with known high-risk electrical disorders.
Lifestyle adjustments matter too. People with CPVT are typically advised to avoid competitive sports and intense exercise. Those with long QT syndrome may need to avoid certain medications (including some common antibiotics and antihistamines) that can further delay the heart’s recharge time. For Brugada syndrome, avoiding fever is important because elevated body temperature can worsen the electrical abnormality.
Why Family Screening Matters
Because SADS conditions are inherited, a single diagnosis or unexplained death in a family has implications for every blood relative. Guidelines recommend that all first-degree relatives (parents, siblings, and children) undergo systematic evaluation, starting with the most accessible and informative tests: a resting ECG and an echocardiogram. Exercise testing is also recommended as a first-line investigation, since it can reveal conditions like CPVT and long QT syndrome that hide at rest.
If a family member died suddenly and tissue was retained, a molecular autopsy can identify the specific genetic mutation responsible. Once a mutation is known, targeted genetic testing for relatives becomes straightforward: a simple blood test can determine who carries the same variant and who does not. Relatives who test negative can be reassured. Those who carry the mutation can begin monitoring and, if needed, preventive treatment before symptoms ever appear.
Screening is ideally coordinated by a specialist experienced in inherited cardiac conditions, because interpreting borderline results requires expertise. A slightly prolonged QT interval, for example, could be normal variation or an early sign of long QT syndrome. Context, including the family history and the specific genetic findings, shapes the interpretation.